Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06850610 · ClinicalTrials.gov registry record · NA
Accuracy Of The Owlet OSS 3.0 During Standardized Stable Hypoxia Plateaus
A NA study of Hypoxia, sponsored by Owlet Baby Care.
- Completed
- Registry status
- NA
- Development phase
- 163
- Enrollment target
- 1
- Study location
NCT06850610: Completed NA study of Hypoxia, sponsored by Owlet Baby Care.
NCT06850610 is a NA study of Hypoxia that has completed, run by Owlet Baby Care. The registered enrollment target is 163 participants, below the 3,113-participant average among 39 other Hypoxia trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06850610, a NA study of Hypoxia, has completed, sponsored by Owlet Baby Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests the accuracy of pulse oximeters in a range of arterial oxygen levels from 100% down to 70%. This is done by comparing the test pulse oximeter readings of young, healthy, adult study participants with blood samples drawn from an artery in the wrist during brief plateaus of progressively lower oxygen saturations. The arterial blood sample is processed in a device called a multi-wavelength hemoximeter and compared to the simultaneous oximeter reading. During each set level of oxygen the participant may be asked to have a motion simulator device apply different types of movement to their hands to assess the pulse oximeter's accuracy during motion. This study will be evaluating the Owlet OSS 3.0 sensor, a component in 2 FDA cleared noninvasive pulse oximeters indicated for infants 1-18 months of age. Testing should require approximately an hour and 15 minutes of the participant's time.
Primary Outcome
* Overall Accuracy: Arms is less than 3%. * Non-Disparate Performance Evaluation 1: Among pairwise comparisons of MST groups 1-4, 5-7, and 8-10, the largest difference in SpO2 bias is less than 3.5% for the interval 70% ≤ SaO2≤ 85% and less than 1.5% for 85%\< SaO2 ≤ 100%. * Non-Disparate Performance Evaluation 2: For a 100-point change in emitter sensor site ITA, the difference in SpO2 bias is less than 3.5% for 70% ≤ SaO2≤ 85% and less than 1.5% for 85%\< SaO2 ≤ 100%
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Pulse oximeter accuracy under hypoxic conditions
Study Locations (1)
California
- Vital Signs Research Group - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2025-02-24 |
| Est. Completion | 2025-08-06 |
| Phase | NA |
What the finished NCT06850610 record still lists
NCT06850610 is an interventional study that assigns participants to a tested intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap, below the 3,113-participant average among 39 other Hypoxia trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Pulse oximeter accuracy under hypoxic conditions is the first listed.
NCT06850610 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06850610 about?
NCT06850610 is a clinical study titled "Accuracy Of The Owlet OSS 3.0 During Standardized Stable Hypoxia Plateaus". This study tests the accuracy of pulse oximeters in a range of arterial oxygen levels from 100% down to 70%. This is done by comparing the test pulse oximeter readings of young, healthy, adult study participants with blood samples drawn from an artery in the wrist during brief plateaus of progressiv...
What is the current status of trial NCT06850610?
This trial is currently completed. It is a NA study. The enrollment target is 163 participants. The study started on 2025-02-24. Estimated completion is 2025-08-06.
What conditions does trial NCT06850610 study?
This clinical trial studies the following conditions: Hypoxia.
What interventions are being tested in trial NCT06850610?
The interventions under investigation include: Pulse oximeter accuracy under hypoxic conditions (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06850610?
This trial is sponsored by Owlet Baby Care, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06850610 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06850610's enrollment target sits among peer trials
163 7th of 39 higher than 33 of 39 other Hypoxia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
RECRUITING · NA
-
The Effects of Endotracheal Suctioning on Pain and Serum Markers
RECRUITING · NA
-
Structural Modification In Supraglottic Airway Device
RECRUITING · NA
-
"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI